We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
+11.3%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$52.3B
AUM Growth
+$4.34B
Cap. Flow
-$146M
Cap. Flow %
-0.28%
Top 10 Hldgs %
26.12%
Holding
2,277
New
427
Increased
521
Reduced
1,052
Closed
79

Top Buys

Rank Stock Value
1
IS
ironSource Ltd.
IS
+$136M
2
TSLA icon
Tesla
TSLA
+$119M
3
VZ icon
Verizon
VZ
+$109M
4
HD icon
Home Depot
HD
+$101M
5
PFE icon
Pfizer
PFE
+$88M

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$247M
2
INTC icon
Intel
INTC
+$216M
3
F icon
Ford
F
+$145M
4
GM icon
General Motors
GM
+$143M
5
MU icon
Micron Technology
MU
+$125M

Sector Composition

Rank Sector Weight
1 Technology 25.15%
2 Healthcare 14.97%
3 Financials 14.22%
4 Consumer Discretionary 11.15%
5 Communication Services 8.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVIR icon
1851
Atea Pharmaceuticals
AVIR
$360M
$266K ﹤0.01%
+29,780
New +$464K
KNTE
1852
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$266K ﹤0.01%
15,000
RXRX icon
1853
Recursion Pharmaceuticals
RXRX
$1.61B
$265K ﹤0.01%
+15,470
New +$291K
OSUR icon
1854
OraSure Technologies
OSUR
$277M
$263K ﹤0.01%
30,318
-54,600
-64% -$540K
ARCT icon
1855
Arcturus Therapeutics
ARCT
$164M
$261K ﹤0.01%
+7,040
New +$287K
AVYA
1856
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$261K ﹤0.01%
+13,170
New +$260K
CDMO
1857
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$260K ﹤0.01%
+8,910
New +$255K
CLDT
1858
Chatham Lodging
CLDT
$638M
$259K ﹤0.01%
18,900
PUMP icon
1859
ProPetro Holding
PUMP
$1.31B
$259K ﹤0.01%
32,020
-107,489
-77% -$978K
PFBC icon
1860
Preferred Bank
PFBC
$1.24B
$258K ﹤0.01%
3,600
-800
-18% -$55.3K
SPNT icon
1861
SiriusPoint
SPNT
$3.1B
$258K ﹤0.01%
31,700
GFL icon
1862
GFL Environmental
GFL
$14.1B
$257K ﹤0.01%
6,800
MNKD icon
1863
MannKind Corp
MNKD
$1.21B
$257K ﹤0.01%
+58,740
New +$272K
RNAM
1864
DELISTED
Avidity Biosciences
RNAM
$257K ﹤0.01%
+10,820
New +$258K
ATNI icon
1865
ATN International
ATNI
$370M
$256K ﹤0.01%
6,408
-6,790
-51% -$290K
MCRB icon
1866
Seres Therapeutics
MCRB
$46.5M
$256K ﹤0.01%
+1,539
New +$245K
AERI
1867
DELISTED
Aerie Pharmaceuticals
AERI
$255K ﹤0.01%
+36,350
New +$380K
AMPH icon
1868
Amphastar Pharmaceuticals
AMPH
$888M
$254K ﹤0.01%
10,900
SKY icon
1869
Champion Homes
SKY
$4.58B
$252K ﹤0.01%
+3,190
New +$230K
AMRS
1870
DELISTED
Amyris Inc.
AMRS
$252K ﹤0.01%
+46,600
New +$435K
SDGR icon
1871
Schrodinger
SDGR
$1.14B
$250K ﹤0.01%
+7,190
New +$328K
AZEK
1872
DELISTED
The AZEK Co
AZEK
$249K ﹤0.01%
+5,380
New +$214K
BLUE
1873
DELISTED
bluebird bio
BLUE
$249K ﹤0.01%
+1,246
New +$294K
OCGN icon
1874
Ocugen
OCGN
$423M
$248K ﹤0.01%
+54,570
New +$412K
ORA icon
1875
Ormat Technologies
ORA
$6.05B
$247K ﹤0.01%
+3,120
New +$236K

Similar funds

Ensign Peak Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Ensign Peak Advisors held 2,277 positions worth $52.3B, up 9% from $48B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Ensign Peak Advisors's Q4 2021 filing shows 427 new, 521 increased, 1,052 reduced and 79 closed positions. Its largest new stake was ironSource Ltd.: 13,801,563 shares worth $107M. The largest sale was AT&T, an estimated $247M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q4 2021 buy was ironSource Ltd.: 13,801,563 shares worth $107M.
  • Ensign Peak Advisors added most to Tesla in Q4 2021, an estimated $119M increase.
  • Ensign Peak Advisors's biggest Q4 2021 reduction was AT&T, cutting an estimated $247M.
  • Ensign Peak Advisors fully exited Acceleron Pharma in Q4 2021, selling an estimated $21.5M.
  • Ensign Peak Advisors's ten largest holdings make up 26% of its $52.3B portfolio in Q4 2021.
  • Ensign Peak Advisors opened 427 new positions and closed 79 in Q4 2021.
  • Ensign Peak Advisors's portfolio value rose 9% quarter-over-quarter to $52.3B.

Based on Ensign Peak Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.